Search Results
328 results
Your search is now limited to «Hepatitis C» expert search.
FeedNavigator 01/19/2019 07:38
Ann Transplant. 2019 Jan 18;24:36-44. doi: 10.12659/AOT.912444.
More from FeedNavigator:
ClinicalTrials.gov 01/18/2019 12:00
Treatment and prophylaxis will be administered using a transmission-triggered approach for the first scenario (HCV Ab+/NAT- donors, arm 1) and a prophylaxis approach for the later scenario (HCV Ab+/NAT+ donors, arm 2.
More from ClinicalTrials.gov:
Healio News 01/18/2019 11:17
We’re really excited to use HepVu to bring attention to the hepatitis C and opioid misuse epidemic and to try and advance awareness programs and policies in this area,” Heather Bradley, PhD, from Georgia State University and project director of HepVu, said during the presentation.
More from Healio News:
Hundreds of thousands of Americans have been cured of Hepatitis C with newly available treatments, yet new Hepatitis C infections have nearly tripled in recent years as a consequence of increasing injection drug use associated with the opioid epidemic.
More from HCV New Drugs And Liver Health:
WN.com 01/17/2019 19:38
Kerry Hayes, 49, from Anacortes, Washington, received a heart from a donor that was infected with the liver disease hepatitis C. After going on eight-week antiviral regimen, he was cured.
More from WN.com:
MedPageToday.com 01/17/2019 16:00
A substantial proportion of newly diagnosed cancer patients were unaware they were concurrently infected with hepatitis B virus (HBV), hepatitis C virus (HCV) or, less frequently, HIV, placing them at risk for serious adverse complications when treated with chemotherapy or other anti-cancer strategies, a SWOG Cancer Research Network study showed.
More from MedPageToday.com:
PR Newswire 01/16/2019 11:00
Hundreds of thousands of Americans have been cured of Hepatitis C with newly available treatments, yet new Hepatitis C infections have nearly tripled in recent years as a consequence of increasing injection drug use associated with the opioid epidemic.
More from PR Newswire:
MPR 01/11/2019 13:30
Due to the limited amount of published literature analyzing treatment options for older chronic HCV infection patients, the study authors aimed to determine the efficacy and tolerability of glecaprevir/pibrentasvir in this population.
More from MPR:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications